Digital Biomarkers represent a cutting-edge frontier in healthcare and medical research, offering a revolutionary approach to monitoring and assessing health using digital technologies. These biomarkers are quantifiable, objective, and measurable indicators derived from various digital sources, such as wearable devices, mobile apps, and sensors. Unlike traditional biomarkers, digital biomarkers capture real-time, continuous data, providing a dynamic and comprehensive view of an individual's health. The utilization of digital biomarkers spans a wide range of applications, including disease monitoring, drug development, and personalized healthcare. Wearable devices, for instance, can track physiological parameters, activity levels, and sleep patterns, offering valuable insights into a person's well-being. The real-time nature of digital biomarkers enables timely intervention and personalized treatment strategies. As digital biomarkers continue to evolve, they hold the promise of transforming healthcare by providing a more holistic and proactive approach to monitoring health, facilitating preventive strategies, and improving overall patient outcomes.
Title : Hepatotoxic botanicals-shadows of pearls
Consolato M Sergi, Universities of Alberta and Ottawa, Canada
Title : Development of novel drug delivery pathways enabled by perillyl alcohol (NEO100), A monoterpene with multifaceted biomedical applications
Axel H Schonthal, University of Southern California, United States
Title : From marker to mechanism: Ligand discovery enables functional analysis of OR51E1, an ectopic olfactory receptor, in prostate cancer
Vladlen Slepak, University of Miami, United States
Title : The impact of metal-decorated polymeric nanodots on proton relaxivity
Paulo Cesar De Morais, Catholic University of Brasilia, Brazil
Title : Principles and standards for managing healthcare transformation towards personalized, preventive, predictive, participative precision medicine ecosystems
Bernd Blobel, University of Regensburg, Germany
Title : Personalized and Precision Medicine (PPM) as a unique healthcare model based on design-inspired biotech- & biopharma-driven applications to secure the human healthcare and biosafety
Sergey Suchkov, N D Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : R&D consultancy at the medicines discovery catapult: De-risking drug discovery for innovators
Adriana Gambardella, Medicine Discovery Catapult, United Kingdom
Title : Biocompatible synthesis of non crystalline iron oxide nanoparticles with stable colloidal properties
Lan Wang, Paretor LLC, United States
Title : Hydrogen sulfide in sepsis: From bench to bedside
Madhav Bhatia, University of Otago, New Zealand
Title : Biocompatibility and subcutaneous host response to silk fibroin–chitosan composite plugs: Progress toward biodegradable implant materials
Luis Jesus Villarreal Gomez, Universidad Autónoma de Baja California, Mexico